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Human chromosome 2nal and paternal genomes are necessary for normal embryogenesis due to parent-
speciﬁc epigenetic modiﬁcation of the genome during gametogenesis, which leads to non-equivalent expression
of imprinted genes from the maternal and paternal alleles. In this study, we identiﬁed a paternally expressed
imprinted gene, Zdbf2, by microarray-based screening using parthenogenetic and normal embryos. Expression
analyses showed that Zdbf2 was paternally expressed in various embryonic and adult tissues, except for the
placenta and adult testis, which showed biallelic expression of the gene. We also identiﬁed a differentially
methylated region (DMR) at 10 kb upstream of exon 1 of the Zdbf2 gene and this differential methylation was
derived from the germline. Furthermore, we also identiﬁed that the human homolog (ZDBF2) of the mouse
Zdbf2 gene showed paternal allele-speciﬁc expression in human lymphocytes but not in the human placenta.
Thus, our ﬁndings deﬁned mouse chromosome 1 and human chromosome 2 as the loci for imprinted genes.
© 2009 Elsevier Inc. All rights reserved.IntroductionGenomic imprinting is an epigenetic gene-marking phenomenon
in mammals, which leads to parent-of-origin-dependent monoallelic
expression of certain genes, termed imprinted genes [1]. To date,
approximately 80 imprinted genes have been identiﬁed in mice, the
majority of which are present in 11 clusters including the Prader–Willi
syndrome/Angelman syndrome and Beckwith–Wiedemann syn-
drome clusters. These clusters were assigned to 8 autosomal
chromosomes, 2, 6, 7, 9, 11, 12, 15, and 17; whereas many solo
imprinted genes have been identiﬁed on 5 chromosomes (numbers 2,
10, 14, 18, and 19). Many of these imprinted genes with expression
patterns were well-conserved between mice and humans. These
genes play an important role in fetal growth, development of
particular somatic lineages, maternal behavior, tumorigenesis, and
birth defects (MRC Mammalian Genetics Unit, Harwell, UK, http://
www.mgu.har.mrc.ac.uk/research/imprinting/function.html).
Gene imprinting is initiated by epigeneticmodiﬁcations such as DNA
methylation that occur in the parental germline. In mammals, DNA
methylation occurs exclusively at the cytosine residueswithin cytosine–
guanine (CpG) dinucleotides, which plays an important role in normal
development [2]. Indeed, many imprinted genes have differentiallyll rights reserved.methylated regions (DMRs), which exhibit parent-of-origin-dependent
DNAmethylationpatterns. SomeDMRs function as cis-acting imprinting
control regions (ICRs) that exert a regional control on gene expression
froman imprinted cluster. Knockoutmice studies demonstrated that the
de novo DNAmethyltransferase Dnmt3a and its related protein Dnmt3L
are required to establish themethylation imprints in both maternal and
paternal germlines [3–5]. Themaintenance methyltransferase Dnmt1 is
then required to maintain the differential methylation and imprinted
expression patterns in the embryo proper [6,7].
A number of studies have suggested that imprinted genes may
have characteristic structural features. For example, it was reported
that imprinted genes tend to have fewer and smaller introns [8]. Other
reports have described that human andmouse imprinted gene regions
contain a lower density of short interspersed transposable elements
(SINEs) than non-imprinted regions [9,10]. Thus far, the presence of
direct repeats near or within the DMRs has been identiﬁed as the
potential feature of these regions [11]. However, these features are not
observed with regard to all imprinted regions, and their functional
relevance is controversial. In a previous study, the dimensions of 15
DMRs (12 maternally imprinted genes and 3 paternally imprinted
genes) weremeasured, and it was revealed that paternallymethylated
DMRs contain fewer CpGs than maternally methylated DMRs [12].
Furthermore, a recent study has demonstrated that the Dnmt3a/
Dnmt3L complex could preferentiallymethylate CpG site pairs that are
8–10 base pairs apart, and a similar periodicity was observed for the
frequency of CpG sites in the 12 maternally imprinted regions [13].
462 H. Kobayashi et al. / Genomics 93 (2009) 461–472However, no other consensus sequence has been identiﬁed for DMRs,
and the features that cause them to get preferentially methylated via
the Dnmt3a/Dnmt3L complex in the germline remain unknown.
After the ﬁrst imprinted gene, Igf2, was identiﬁed in a knockout
study, many other methods have subsequently been used to identify
imprinted genes in mice. In 1994,U2afbp-rs (Zrsr1) [14] and Rasgrf1 [15]
were identiﬁed as paternally expressed genes with the use of
methylation-sensitive restriction enzyme sites as the restriction land-
mark in the restriction landmark genomic scanning (RLGS) method for
screening methylated sites. Subsequently, Ishino's group identiﬁed 2
paternally expressed genes, namely, Peg1 (Mest) and Peg3, and 2 mater-
nally expressed genes,Meg1 (Grb10) andMeg3, by comparison analysis
of geneexpression among invitro fertilizedparthenogenetic (containing
only maternally derived chromosomes) and androgenetic (containing
only paternally derived chromosomes) embryos, by suppression
subtractive hybridization [16–19]. In 1997, the paternally expressed
gene Impact was identiﬁed using allelic message display without
positional cloning or production of parthenogenetic and androgenetic
embryos [20]. Furthermore, the development of DNA microarray
technology facilitated the identiﬁcation of many imprinted genes by
gene expression proﬁling. In 2000, Affymetrix GeneChip was used with
in vitro fertilized and parthenogenetic embryos and, in 2002, RIKEN
cDNA Microarray was used with parthenogenetic and androgenetic
embryos to identify new imprinted genes [21,22]. Further, in 2006,
AffymetrixGeneChipwasusedwith uniparental disomies [23]. Recently,
the imprintedMcts2 gene was identiﬁed using the sequence features of
imprinted genes [24], indicating that bioinformatics analysis can
contribute to the identiﬁcation of novel imprinted genes. Although a
recent study has estimated that there are 600 imprinted genes in mice
[25], a complete global analysis for locating imprinted genes has not
been performed. To elucidate the biological importance of genomic
imprinting and other characteristics of imprinted genes, it is important
to systematically identify the remaining imprinted genes.
In this study, we compared the gene expression proﬁles between
parthenogenetic and in vitro fertilized embryos (control) by using the
Affymetrix GeneChip probe array to identify novel imprinted genes. The
control embryos containing both the maternal and paternal genomes
exhibited normal expression patterns of bothmaternally and paternally
expressed genes; however, the parthenogenetic embryos that contain 2
maternal genomes exhibited a signiﬁcantly decreased expression of
paternally expressed genes. On the basis of this information, we
screened the imprinted gene candidates and conﬁrmed the imprinted
expression of these genes by using reverse transcriptase-polymerase
chain reaction (RT-PCR) analysis. From this screening, we identiﬁed a
paternally expressed imprinted gene, Zdbf2, on mouse chromosome 1.
We also identiﬁed a DMR in the paternal allele methylated at 10 kb
upstream of the predicted exon 1 of the Zdbf2 gene. Furthermore, we
demonstrated that the human homolog ZDBF2, which is mapped to
chromosome 2, is also paternally expressed. The newly identiﬁed
imprinted genes provide an opportunity to further investigate the
function and mechanisms of the genomic imprinting machinery.
Results
Screening for new imprinted gene candidates by microarray analyses
In this study, we compared the global expression proﬁles of mouse
parthenogenetic and in vitro fertilized (control) embryos by using theFig. 1. Comparison between the control and parthenogenetic samples. The red lines
indicate equal expression levels between the 2 samples. The pink lines indicate a 2-fold
change in the expression levels between the 2 samples. (A) Scatter plots of all the genes.
(B) Scatter plots of candidate genes. (C) Scatter plots of known imprinted genes
obtained by our screening. Partheno: parthenogenetic embryos (n=4); control: in vitro
fertilized control embryos (n=4).
Table 1
Genes identiﬁed by microarray analysis between the control and parthenogenetic embryos
Control Systematic GenBank accession Common name Fold
change
Control Parthenogenetic Chromosome
Raw Normalized Raw Normalized
b500 raw 1423294_at AW555393 Mest 96 9196.1 1 84.2 0.01 6
1448152_at NM_010514 Igf2 28.4 6508.5 1.01 253.6 0.04 7
1426208_x_at AF147785 Plagl1 97.3 5727.5 0.97 9.8 0.01 10
1421144_at NM_023879 Rpgrip1 5.5 5316.2 0.97 1460.6 0.18 14
1433924_at BM200248 Peg3 84.9 4702.7 1.02 34.5 0.01 7
1425966_x_at D50527 Ubc 5.5 4289.8 0.96 884.1 0.17 5
1417355_at AB003040 Peg3 88.2 3949.5 1.02 30 0.01 7
1423506_a_at AV218841 Nnat 97.7 3321.8 0.98 13.4 0.01 2
1435383_x_at AW743020 Ndn 90.5 3216.6 1.03 23.6 0.01 7
1435382_at AW743020 Ndn 78.7 3115.9 1.03 36 0.01 7
1455792_x_at AV124445 Ndn 99.6 2982 1 4.5 0.01 7
1415923_at NM_010882 Ndn 100.2 2871.3 1 4 0.01 7
1437853_x_at BB074430 Ndn 81.9 2585.1 1 30.3 0.01 7
1417356_at AB003040 Peg3 102.9 2394.6 1.03 4.6 0.01 7
1417184_s_at BC027434 Hbb-b1 7 1944 1.01 286.3 0.14 7
1449939_s_at NM_010052 Dlk1 6.5 1668.7 1.07 291.2 0.17 12
AFFX-18SRNAMur/X00686_5_at AFFX-18SRNAMur/X00686_5 Pigta 8.9 1622 2.33 56.9 0.26 2
1417714_x_at NM_008218 Hba-a1 7.6 1470.9 1.15 222.8 0.15 11
1415896_x_at NM_013670 Snrpn 28 1336 1.01 53.4 0.04 7
1435716_x_at AI836293 Snrpn 102.7 916.7 1.04 5.1 0.01 7
1421063_s_at NM_033174 Snrpn 104.8 807.3 1.05 1.2 0.01 7
1451058_at AV017653 Mcts2 17.6 766.6 1.04 46.9 0.06 2
1428111_at AK003626 Slc38a4 16.9 710.8 1.01 67.8 0.06 15
1448889_at NM_027052 Slc38a4 31.6 629.1 1 36.6 0.03 15
1415911_at NM_008378 Impact 5.2 618.1 0.94 127.6 0.18 18
1420688_a_at NM_011360 Sgce 8.3 558.6 1.04 86.6 0.13 6
1457356_at BI793602 Airn 33.4 550 1 20.5 0.03 17
1457781_at BG063584 Kcnq1 33.4 537.2 0.97 19 0.03 7
1455966_s_at BG070110 5.5 502.8 1.01 156.6 0.18 b
1458161_at BM248551 Kcnq1 68.1 500.6 1 8.3 0.01 7
b400 raw 1456783_at BB075402 9330107J05Rik 14.9 467.5 0.98 39.2 0.07 1
1427797_s_at BF580235 5.4 413.9 0.87 80.4 0.16 b
1437213_at BG070110 6 411.3 0.98 128.7 0.16 b
b300 raw 1452705_at AK004611 Pdxdc1 5.5 355.2 0.59 117.4 0.11 16
1455087_at AV328498 D7Ertd715e 103 341.8 1.03 0.7 0.01 7
1445966_at BG075586 Airn 15 310.6 0.99 22.7 0.07 17
1456139_at BM124989 Airn 90.1 309.2 0.97 2.8 0.01 17
b200 raw 1451634_at BC009123 Airn 19.8 271.1 1.01 19.8 0.05 17
1427127_x_at M12573 Hspa1b 5.1 240.5 0.98 45.3 0.19 17
1436964_at BB314814 D7Ertd715e 62.9 234.3 0.63 0.8 0.01 7
1452646_at AK003956 Trp53inp2 7.6 216 0.95 40.4 0.13 2
1451386_at BC027279 Blvrb 6.9 204.3 0.97 49.4 0.14 7
b100 raw 1458179_at BB526903 Airn 36.6 169 1.01 6.1 0.03 17
1424010_at BC022666 Mfap4 16.3 167.1 1.04 12.6 0.06 11
1450533_a_at NM_009538 Plagl1 81.4 166.3 0.99 2.1 0.01 10
1443007_at AW545941 Gnas 8.9 162 0.94 19 0.11 2
1439483_at BI438039 AI506816 12 155.7 0.53 9.4 0.04 b
1418632_at BI694835 Ube2h 5.6 147.7 1.01 38.5 0.18 6
1420978_at NM_010938 Nrf1 5.1 132.4 0.9 44.6 0.17 6
1442029_at BM250850 Kcnq1 68 132.2 0.96 1.5 0.01 7
1426009_a_at BC003763 Pip5k1b 6.3 130.1 0.98 42.1 0.15 3
1417217_at NM_013779 Magel2 6.3 129.5 0.98 27 0.16 7
1453164_a_at AI596401 Ptdss2 9.8 126.2 0.99 22.1 0.1 7
1453224_at AW049828 Zfand5 8 117.9 0.99 25.8 0.12 19
1450383_at AF425607 Ldlr 5.7 110.3 0.84 23 0.15 9
1420406_at NM_013788 Peg12 71.3 105.4 0.97 1.3 0.01 7
1434952_at BI734783 5.7 101.8 0.95 32.2 0.17 8
1429115_at AK008077 2010003O02Rik 9.3 101.7 0.96 13 0.1 4
Genes indicated in bold are known imprinted genes.
a Was used as a control gene; therefore, it was excluded from the list of candidate genes.
b These sequences matched at more than 2 loci.
463H. Kobayashi et al. / Genomics 93 (2009) 461–472Affymetrix GeneChip assay to identify novel imprinted genes.
Logically, the expression of an imprinted gene transcribed from the
paternally inherited allele will be repressed in parthenogenetic
embryos as compared to control embryos. In the microarray analysis,
4 parthenogenetic samples and 4 control samples were hybridized to
the GeneChip (Fig. 1A). We used 2 approaches for screening
candidates of paternally expressed genes. First, we excluded genes
whose raw expression intensities were below 100 in the control
embryos, because analysis of genes with low intensities wouldproduce unreliable results. Second, we selected genes whose normal-
ized data in parthenogenetic embryos was more than 5-fold lower
than that of control embryos (Table 1). By this screening, we obtained
21 imprinted gene candidates (Fig. 1B), which seemed to be
predominantly expressed by paternal allele, excluding 18 known
imprinted genes (Fig. 1C). Of the 18 known imprinted genes obtained,
16 genes were known as paternally expressed genes. Therefore, the
results of the microarray analysis were reasonable because there is
down-regulation of the imprinted genes in parthenogenesis.
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We investigated the polymorphisms in the candidate genes among
C57BL/6, DBA/2, and JF1 mice in order to conﬁrm that these
candidates are true imprinted genes by allele-speciﬁc RT-PCR
sequencing analysis. The polymorphism analyses of the candidate
genes revealed polymorphisms in a total of 13 candidates: 2
candidates (GenBank accession numbers D50527 and NM_010938)
between C57BL/6 and DBA/2 mice, 9 candidates (BB075402,
AK004611, BC027279, BI694835, BC003763, AI596401, AF425607,
BI734783, and AK008077) between C57BL/6 and JF1 mice, and 2
candidates (NM_008218 and BC027434) among C57BL/6, DBA/2, and
JF1 mice (Table 2). To identify the alleles of these genes that were
predominantly expressed, we performed RT-PCR sequencing of the
candidate genes using BDF1 (C57BL6×DBA/2), DBF1 (DBA/
2×C57BL/6), JBF1 (JF1×C57BL/6), and BJF1 (C57BL/6×JF1) mouse
embryos at the 9.5-day-old stage (E9.5). All the primer sets for this
analysis are listed in Supplemental Table 1. Allele-speciﬁc RT-PCR
sequencing analysis showed that the BB075402 transcript was
expressed only from the paternal allele (Fig. 2).
Expression analysis of mouse Zdbf2—a novel imprinted gene
According to the NCBI Entrez Gene database (http://www.ncbi.
nlm.nih.gov/sites/entrez?db=gene), the 655-bp region of the
BB075402 sequence corresponded to the 3′-untranslated region
(UTR) of the Zdbf2 (zinc ﬁnger, DNA binding factor type containing
2) gene, which contains 7 predicted exons (Fig. 3A). The Zdbf2 gene
was mapped to mouse chromosome 1C2 (Gene ID: 73884). First, we
designed 3 speciﬁc primer sets (Z1, Z2, and Z3; Z1 primers were used
in allele-speciﬁc RT-PCR sequencing analysis) for the 3 expressed
sequence tags (ESTs) (BB075402, AK033878, and AK015271) that
matched the predicted complete Zdbf2 gene structure in order to
conﬁrm the expression levels of the gene (Fig. 3A). Incidentally, the
AK033878 transcript (3113 bp) corresponds to the 3′-UTR region of
the Zdbf2 gene, and is registered as a candidate mouse imprinted
transcript in the RIKEN database (http://fantom2.gsc.riken.jp/
EICODB/imprinting/). The AK015271 transcript (984 bp) spliced
fragment contains exons 1–7 of the Zdbf2 gene. The microarray
assay showed that the BB075402 transcript expression level in the
parthenogenetic embryos was 8% (the expression level of the controlTable 2
DNA polymorphism information of each paternally expressed candidate gene
All polymorphisms are shown in red.
a No polymorphisms were identiﬁed.
b No PCR bands were detected by RT-PCR.was 100%) (Fig. 3B). The results of real-time PCR showed that the
expression levels of the BB075402 transcript (Z1) and AK033878 (Z2)
in the parthenogenetic embryos were 2% and 3%, respectively (Fig. 3C,
D). Furthermore, results of the RT-PCR conducted for the AK015271
transcript (Z3) containing exons 5–7 showed a PCR band in the control
embryo, but no such band was detected in the parthenogenetic
embryo (Fig. 3E). Thus, we conﬁrmed the repression of the Zdbf2 gene
in parthenogenesis. Second, we designed another primer set (Z4) for
the translated region at exon 7 of the Zdbf2 gene to conﬁrm whether
this gene is imprinted. We identiﬁed a single nucleotide polymorph-
ism (SNP) in the Z4 region between B6 and JF1 mice. Further, allele-
speciﬁc RT-PCR sequencing analysis using BJF1 and JBF1 embryos at
E9.5 showed that the transcript at the Z4 region was paternally
expressed (Fig. 3F). In addition, 5′-rapid ampliﬁcation of cDNA ends
(RACE) analysis of the Zdbf2 gene, which was performed using BJF1
mouse embryos at E9.5, showed that the expressed transcript almost
completely matched exons 1–7 of AK015271; however, exons 1 and 2
were partially matched, and exon 5 was 30 bp longer than that in the
transcripts (Supplemental Fig. 1). These results suggest that the
mouse Zdbf2 gene transcript containing at least 7 exonswas paternally
expressed.
Expression analysis of mouse Zdbf2 in differential developmental stages
and tissues
Next, we investigated the Zdbf2 gene expression pattern in mice
during 4 differential developmental stages: 15.5- and 18.5-day-old
embryos (E15.5 and E18.5) and 1- and 9-week-old mice. Further, the
pattern was investigated by RT-PCR analysis (at Z1 and Z4 regions) of
various mouse tissues: the brain, tongue, heart, liver, lung, kidney, and
muscle at all ages; the intestineandplacenta in onlyembryos; the spleen
in only 1- and 9-week-old mice; and the testis in only 9-week-old adult
mice (Fig. 4). Results of the BB075402 (Z1) transcript analysis showed
that gene expression was detected in almost all the major tissues from
E15.5 and E18.5, except the liver and intestine, which did not show
detectable expression in a few cases (Fig. 4A, Supplemental Fig. 1).
Furthermore, allele-speciﬁc RT-PCR sequencing of BB075402 was
performed for all the tissues (strong expression was detected) of BJF1
embryos at E15.5 and 9-week-old adult mice. Interestingly, although
almost all the tissues were paternally expressed, placentas from the
E15.5 embryos and adult testis exhibited biallelic expression (Fig. 4C,
Fig. 2. Expression analysis of BB075402. Allele-speciﬁc RT-PCR sequencing analysis of
BB075402 was performedwith C57BL/6 (B6), JF1, BJF1, and JBF1mouse embryos at E9.5
(n=3). The SNP of BB075402 is highlighted in yellow.
465H. Kobayashi et al. / Genomics 93 (2009) 461–472Supplemental Fig. 2). Meanwhile, expression at the Z4 region was
detected in the brain, tongue, heart, lung, intestine, kidney, muscle, and
placenta in E15.5 embryos and in the brain, tongue, kidney, muscle, and
placenta in E18.5 embryos (Fig. 4B). Allele-speciﬁc RT-PCR sequencingofthe Z4 region showed similar results to that of BB075402 (data not
shown). These results strongly suggested that the transcript of the
mouseZdbf2 gene is paternally expressed in almost all expressed tissues,
but is biallelically expressed in only the placenta and testis.
Parent-of-origin-speciﬁc methylation of the mouse Zdbf2 gene
Many imprinted genes are epigenetically regulated by epigenetic
mechanisms such as DNA methylation. DNA methylation occurs
exclusively at cytosine residues within CpG dinucleotides. DMRs
have been identiﬁed in CpG-rich regions (CpG islands) around
imprinted genes in the maternal and paternal genomes, and it has
been demonstrated that these regions function as ICRs. To explore
and understand the regulation of the imprinted Zdbf2 gene, we
analyzed the DNA methylation status by using the bisulﬁte
sequencing method [26].
The genomic DNA sequence of the mouse Zdbf2 gene was derived
from the mouse BAC clone RP23-434D24 (GenBank accession number
AL669947, Fig. 5A). First, we identiﬁed 3 putative CpG islands within
the AL669947 sequence using EMBOSS CpGplot (http://www.ebi.ac.
uk/emboss/cpgplot/), and termed them CG1, CG2, and CG3 (Fig. 5A).
These CpG islands were deﬁned as a 200-bp stretch of DNA with a GC
content of over 50% and an observed CpG/expected CpG (Obs/Exp
CpG) ratio greater than 0.6. The CG1 region was observed 25 kb
upstream of the Zdbf2 gene. CG2 contains the promoter and exon 1 of
the Zdbf2 gene. We identiﬁed some SNPs in the CG1 and CG3 regions
but not in CG2 by direct sequencing of samples from C57BL/6 and JF1
mice (Table 3). The CG3 contains 29 copies of the cytosine-rich 18-bp
direct repeat and is included in exon 7 (Supplemental Fig. 3). To
examine the differential methylation between paternal and maternal
alleles in these CpG islands, we subjected them to bisulﬁte sequencing
analyses for the CG1 and CG3 regions using 9.5-day-old in vitro
fertilized embryos (BJF1 mice) and for the CG2 region using 9.5-day-
old parthenogenetic and androgenetic embryos. The results showed
that all the analyzed regions were almost unmethylated in both the
alleles (Fig. 5B–D).
Second, by changing the CpG island criteria (minimum length,
100 bp; GC content, N50%; Obs/Exp CpG, N0.6), we identiﬁed a
relatively CpG-rich region 10 kb upstream of the Zdbf2 gene,
between the CG1 and CG2 regions, and also identiﬁed SNPs in this
region between C57BL/6 and JF1 mice (Table 3). We performed
bisulﬁte sequence analysis for this region similar to the 3 CpG islands
(Fig. 5E). Interestingly, paternal allele-speciﬁc methylation was
detected in the CpG-rich region. Furthermore, bisulﬁte sequencing
analyses of oocytes and sperms revealed that this region was
hypomethylated in oocytes but highly methylated in sperms. These
results showed that this CpG-rich region was methylated on the
paternal alleles and that the methylation was derived from germline,
similar to H19 DMR, Dlk1-Gtl2 IG-DMR, and Rasgrf1 DMR, which are
known as paternal methylation imprints [27–29]; thus, we termed
this region Zdbf2 DMR.
Human homologous ZDBF2 is paternally expressed in lymphocytes but
not in the placenta
Most known imprinted genes have been identiﬁed among
mammalian species, especially in mice and humans, but species-
speciﬁc imprinting has been reported in some genes, like Igf2r and
Impact [30,31]. To verify the imprinting status of the human homolog
ZDBF2, we examined an SNP in the ZDBF2 gene by direct sequencing
of cDNA from human tissues. On the basis of the NCBI Entrez human
gene database, the human homolog ZDBF2 gene containing 5 exons
was mapped to chromosome 2q33.3 (Gene ID: 57683), and no
imprinted genes were identiﬁed on human chromosome 2. We
designed a primer set within the last exon of ZDBF2 (exon 5)
including the SNP (reference SNP ID: rs10932150). We then
Fig. 3. Expression analysis of a novel paternally expressed gene, Zdbf2, on mouse chromosome 1. (A) Map of the Zdbf2 gene on chromosome 1. Three EST positions and the primer
positions of the Z1–Z4 regions are shown in the map. (B) Expression analysis of BB075402 by the microarray method. Partheno: parthenogenetic embryos (n=4); control: in vitro
fertilized control embryos (n=4). Expression analysis of the Z1 (BB075402) (C) and Z2 regions (AK033878) (D) by real-time RT-PCR in the parthenogenetic (n=3) and control
embryos (n=3). Values are expressed as mean±s.e.m. (E) Expression analysis of the Z3 region (AK0152712) by RT-PCR in the control and parthenogenetic embryos. (F) Allele-
speciﬁc RT-PCR sequencing analysis of the Z4 region with B6, JF1, BJF1, and JBF1 mouse embryos at E9.5 (n=3). The SNP of Z4 is highlighted in yellow.
466 H. Kobayashi et al. / Genomics 93 (2009) 461–472performed RT-PCR analysis using human lymphocytes from a child
who was heterozygous for a G/A polymorphism at the rs10932150
site, and only allele A from the father was detected (Fig. 6A, B).
Furthermore, we examined the SNP in the human placenta, which
was also heterozygous and, surprisingly, both G and A alleles were
detected (Fig. 6C). These results revealed that the human ZDBF2 gene
is paternally expressed in lymphocytes but biallelically expressed in
the placenta. This placenta-speciﬁc gene escape from imprinting is
similar to that observed in the imprinted mouse ZDBF2 gene. These
results demonstrated that an imprinted locus is present on human
chromosome 2.Discussion
This study aimed to identify novel imprinted genes by compre-
hensive comparison of mouse gene expression. We successfully
identiﬁed a imprinted gene, Zdbf2, which was mapped to mouse
chromosome 1C2, and its imprinted human homolog, ZDBF2, which
was mapped to human chromosome 2q33.3. The discovery of the
imprinted Zdbf2 gene may provide an opportunity to identify
additional imprinted genes in the vicinity of this gene because of
the clustering tendency of imprinted genes. Currently, the function of
the Zdbf2/ZDBF2 gene is unknown. Meanwhile, previous studies
Fig. 4. Stage- and tissue-speciﬁc expression of the Zdbf2 gene. Expression analysis by RT-PCR of Z1 (A) and Z4 (B) in the tissues (B = brain, T = tongue, H = heart, Li = liver, Lu =
lung, I = intestine, K= kidney, S = spleen, M=muscle, P= placenta, and Te= testis; n=3, respectively) of BJF1 mouse embryos at 15.5 and 18.5 days (E15.5 and E18.5) and 1- and
9-week-old adult mice (1 week and 9 weeks). (C) Allele-speciﬁc RT-PCR sequencing analysis of Z1 (BB075402) using B6 and JF1 mouse embryos at E9.5, the brain and placenta from
BJF1 embryos at E15.5, and the testis from adult BJF1 mice (n=2). The SNP of BB075402 is highlighted in yellow.
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human chromosome 2 were responsible for various abnormalities
[32–35]. Investigating the functions of the Zdbf2 gene and other
imprinted genes may provide further information about the imprint-
ing disorders and mechanism.
In this study, we compared gene expression proﬁles between
parthenogenetic and in vitro fertilized embryos (control) using the
Affymetrix GeneChip probe array. We obtained 18 known imprinted
genes and 21 candidates of paternally expressed genes. Some of the
known imprinted genes included paternally expressed genes that
were previously identiﬁed using subtraction hybridization in 9- to
10-day-old parthenogenetic and control embryos, similar to those
used in our study [16,17,21,36], or embryonic ﬁbroblast cell lines [37].
Of the obtained known imprinted genes, Kcnq1 and Gnas are known
as maternally expressed genes. These genes were accompanied by a
paternally expressed antisense gene (Kcnq1ot1) or an alternative
gene form (Gnasxl); therefore, these transcripts might be hybridized
to the array [38,39]. Although we obtained several known imprinted
genes from this screening, we could not obtain all the known
imprinted genes. The reasons may include the decreased detection
capability of tissue-speciﬁc imprinted gene expression because of
RNA isolation from whole embryos or immature organ formation of
each sample.
Of the 21 paternally expressed gene candidates, we identiﬁed
polymorphisms among C57BL/6, DBA/2, and JF1 mice with 13
candidates. We used RT-PCR analysis and identiﬁed that of these,
the BB075402 transcript was expressed only from the paternal allele.
Meanwhile, many paternally expressed gene candidates exhibitedbiallelic expression in RT-PCR analysis. The differential expression of
such genes between parthenogenetic and control embryos could be
explained using 2 reasons. First, since 9.5-day-old parthenogenetic
embryos exhibited delayed development as compared to the controls
at the same stage of development, stage-speciﬁc genes might have
been selected in this screening. Second, disruption of the imprinted
gene expression in parthenogenesis might affect the expression of the
non-imprinted genes, which were detected as false imprinted genes.
These arguments were described in the discussion section of the
previous studies [22,40]. The remaining candidate genes in which no
polymorphisms were detected need to be further evaluated to
determine whether they are true imprinted genes. Further investiga-
tion with other reciprocal crosses would be useful for identifying
polymorphisms between the strains.
The BB075402 transcript was registered as a RIKEN mouse EST
obtained from adult male diencephalons, and our study demonstrated
expression of the BB075402 transcript (Z1 region) in the brain.
Though almost all the major tissues showed clear expression of this
transcript during embryogenesis, the tissues expressing this gene
were limited to the brain, tongue, and muscle, and the testis after
birth. The 3′-region of the AK033878 transcript corresponds to the
BB075402 transcript, and both transcripts showed decreased expres-
sion in parthenogenetic embryos. Moreover, a part of the AK015271
transcript (Z3 region), which contains exons 1–7 of the mouse Zdbf2
gene, was observed to show decreased expression in parthenogenetic
embryos as determined by RT-PCR. We could further perform allelic
expression analysis on the translated region (Z4 region shown in
Fig. 3) of the mouse Zdbf2 gene, and the results revealed that the
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Table 3
DNA polymorphism information on each CpG-rich region surrounding the mouse Zdbf2
gene
All polymorphisms are shown in red.
a No polymorphisms were identiﬁed.
469H. Kobayashi et al. / Genomics 93 (2009) 461–472translated region was paternally expressed similar to the BB075402
transcript. These results strongly indicated that these transcripts were
the same products expressed solely from the paternal allele. It
appeared that exons 5–6 of Zdbf2 are also paternally expressed;
however, it remained unknown as to whether the large (13 kb)
transcript of the Zdbf2 gene is expressed. Therefore, we tested 5′-RACE
using mouse embryos at E15.5, and we could conﬁrm that the
expressed splice form (exons 1–7) was almost identical to the
AK015271 transcript. Meanwhile, Z1 and Z4 primers did not detect
expression in all the same tissues. For example, in embryonic liver,
expression of the Z1 region was detectable but the Z4 region was not.
Though this may be caused by the presence of different forms of the
Zdbf2 transcript in different tissues, to reveal (tissue-speciﬁc) splice
variants of Zdbf2 gene is required in future.
According to the database, the mouse Zdbf2 gene encodes a 2493-
amino acid proteinwith a predicted mass of 270 kDa. In our study, we
demonstrated that the human ZDBF2 gene was paternally expressed
in lymphocytes. Furthermore, the human unidentiﬁed gene-encoded
(HUGE) protein database of the Kazusa DNA Research Institute
provides the expression proﬁle of the human ZDBF2 gene based on
RT-PCR and enzyme-linked immuno-sorbent assay (ELISA) [41]. It is
shown that the expression level of this gene in the brain andmuscle is
higher than that in other tissues such as those in the heart, lung, liver,
kidney, pancreas, and spleen (http://www.kazusa.or.jp/huge/
gfpage/KIAA1571/). Interestingly, our study showed that mouse
Zdbf2 gene expression was detected in only the brain, tongue, and
muscle through the embryo to the adult stages. Thus, the expression
proﬁle of human ZDBF2was similar to that of mouse Zdbf2, which was
investigated in our study. Furthermore, analyses of imprinted
expression patterns showed that biallelic expression of mouse and
human homologs was detected in placental tissues despite the
paternal allele-speciﬁc expression observed in almost all other tissues
(except for the testis) The possibility of placental tissues containing
maternal materials was not completely excluded, however, the other
imprinted gene (H19) showed normal imprinted expression pattern
in both human and mouse placental tisses (data not shown). These
facts indicate that the regulation mechanism of Zdbf2/ZDBF2 gene
expression is well conserved between mice and humans. Further
comparison analyses of Zdbf2/ZDBF2 gene products may provide hints
for revealing those functions. For example, additional homologous
Zdbf2 anchors among chimpanzees, rats, dogs, horses, and chickens
have been identiﬁed (Gene ID: 470622, 501153, 488490, 100068542,
and 424100). These facts indicated that this gene plays an evolution-Fig. 5.Methylation proﬁles of Zdbf2 DMR and CpG islands surrounding the mouse Zdbf2 gene
the positions of each CpG island, i.e., CG1, CG2, and CG3. The open vertical arrowhead ind
arrowheads indicate the positions of each CpG island—CG1, CG2, and CG3. The methylation s
n=2), parthenogenetic, and androgenetic embryos (n=2). Coordinates are fromGenBank Se
the CG3 region. (E) Methylation of Zdbf2 DMR in the 9.5-day-old in vitro fertilized (BJF1 mi
unmethylated CpGs. The asterisks represent polymorphism positions between B6 and JF1 m
between C57BL6 (B6) and JF1 mice. Mat, maternal (B6) allele; Pat, paternal (JF1) allele. n:ally conserved role among at least these organisms. There were no
reports of the imprinted genes showed biallelic expression speciﬁcally
in placenta and testis, like Zdbf2 gene. By contract, some imprinted
genes shows placenta-speciﬁc imprinted expression, and one of them,
Mash2/Ascl2 gene is essential for placental development [42]. The
elucidation of the function of Zdbf2 genemay explain the reason of the
placenta- and testis-speciﬁc escape imprinting.
As previously noted, imprinted genes were regulated by parent-
of-origin-speciﬁc DNA methylation in the DMR in cis. On analyzing
the DNA methylation status at 4 CpG-rich regions around the mouse
Zdbf2 gene, we identiﬁed a paternal allele-speciﬁc methylated region,
Zdbf2 DMR, which is 10 kb upstream of the Zdbf2 gene. Thus far,
similar DMRs have been found in only 3 imprinted loci—H19-Igf2,
Dlk1-Gtl2, and Rasgrf—and it has been demonstrated that these DMRs
function as the ICRs controlling the neighboring imprinted genes. In
particular, methylation of H19 DMR and Dlk1-Gtl2 IG-DMR acts as
paternal methylation imprinting and prevents parthenogenesis
[43,44]. Interestingly, 2 paternally expressed genes, Igf2 and Dlk1,
were included in the 18 known imprinted genes that were obtained
from our microarray screening. This indicates that hypomethylation
of H19 DMR and IG-DMR inhibits paternally expressed genes on both
maternal alleles in a parthenogenetic embryo, and that the methyla-
tion of Zdbf2 DMR may also regulate the paternally expressed Zdbf2
gene and the hitherto undiscovered neighboring imprinted genes.
Moreover, the methylation of Zdbf2 DMR might be established in
gonocytes because the other 3 paternal methylation imprints are
established in this stage [45–49], but the details of this remain
unknown. The regulatory mechanism of the Zdbf2 gene and the role
of DNA methylation at the Zdbf2 DMR should be clariﬁed. The
identiﬁcation of novel paternally methylated DMRs was important
and valuable, because only 3 cases showing such methylation
patterns were reported, even though over 10 maternally methylated
DMRs were reported. Further characterization of Zdbf2 DMR is
required to demonstrate the mechanisms by which the paternally
methylated DMRs were methylated (targeted) by DNA methyltrans-
ferases. Although the real role of the repeat element in genomic
imprinting [50,51] is still unknown, we identiﬁed a direct repeat
sequence on the Zdbf2 gene, similar to the other imprinted genes. In
conclusion, we successfully deﬁned mouse chromosome 1 and
human chromosome 2 as the imprinted loci. Our ﬁndings provide a
new platform for further identiﬁcation of new imprinted genes and
new insight into control of parental gene expression.
Materials and methods
Extraction of total RNA from parthenogenetic, androgenetic, and control
embryos for microarray analysis
Parthenogenetic and androgenetic embryos were prepared as
described previously [52]. Brieﬂy, parthenogenetic embryos were
constructed by stimulating unfertilized BDF1 eggs (C57BL6×DBA/2;
Clea Japan, Tokyo, Japan) with strontium chloride solution, which
contains cytochalasin B to prevent extrusion of the second polar body.
Androgenetic embryos were produced by in vitro fertilization of
enucleated oocytes from BDF1 mice. Pronuclear transfer (from male
BDF1 mice) was performed to produce diploid androgenetic embryos.
Control biparental embryos were produced by the in vitro fertilization
of non-manipulated oocytes. These embryos were introduced into an. (A) Genomic structure of the mouse Zdbf2 gene. The ﬁlled vertical arrowheads indicate
icates the position of the relatively CpG-rich region, i.e., Zdbf2 DMR. The ﬁlled vertical
tatus of (B) CG1, (C) CG2, and (D) CG3 in the 9.5-day-old in vitro fertilized (BJF1 mice;
quence AL669947. The 29 continuous arrows (horizontal) indicate direct repeats within
ce) embryos, oocytes, and sperm. The open and closed circles indicate methylated and
ice. The maternal and paternal alleles were distinguished by polymorphisms, if present,
number of DNA clones.
Fig. 6. Expression analysis of the ZDBF2 gene on human chromosome 2. (A) Genomic structure of the human ZDBF2 gene. The arrow indicates the position of the SNP (ID:
rs10932150). The SNP sequence is indicated in red. Allele-speciﬁc RT-PCR sequencing analysis in (B) the human lymphocyte cell line and (C) placenta. The SNP of exon 5 is
highlighted in yellow.
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were harvested, and TRIzol (Invitrogen, Carlsbad, CA) was used to
extract total RNA from the embryos.
cRNA preparation and microarray hybridization
A 1-μg aliquot of total RNA was used as the template for cDNA
synthesis (Eukaryotic Poly-A RNA Control Kit and One-Cycle cDNA
Synthesis Kit; Affymetrix, Santa Clara, CA). The cDNA was puriﬁed
with the Sample Cleanup Module (Affymetrix). Following cleanup,
biotin-labeled cRNAwas synthesized using the GeneChip IVT Labeling
Kit (Affymetrix), and fragmented and puriﬁed with the Sample
Cleanup Module (Affymetrix). The fragmented cRNA was hybridized
with Affymetrix Mouse genome 430 2.0 GeneChip at 45 °C for 16 h.
The GeneChips were then washed and stained with a GeneChip
Fluidics Station 460 (Affymetrix) according to the Expression Analysis
Technical Manual. An Affymetrix GeneChip Scanner 3000 was used to
quantify the signal.
Microarray data analyses
The Affymetrix Mouse genome 430 2.0 GeneChip contains 45101
genes and ESTs. We compared the parthenogenetic embryos with
control embryos by using the following 3 normalization methods:
data transformation, where the set measurements were less than
0.01–0.01; per chip normalization, where the values were normalized
to the 50th percentile to limit the range of variation; and per gene
normalization, where the values were normalized to speciﬁc samples.
Polymorphism analyses among candidate genes
C57BL/6 and DBA/2 mice were purchased from Clea Japan, and
JF1 mice [53] obtained from the National Institute of Genetics in
Mishima, Japan. Genomic DNAwas isolated from the tails of C57BL/6,
DBA/2, and JF1 mice by digestion with proteinase K (Invitrogen),
which was followed by phenol/chloroform extraction. The DNA wasampliﬁed by PCR with TaKaRa Ex Taq polymerase (TaKaRa, Kyoto,
Japan). The primer sequences were complementary to the exon
sequences of the candidate genes, and the PCR conditions are listed in
Supplemental Table 1. The PCR products were puriﬁed with Wizard
SV Gel and the PCR Clean-Up System (Promega, Madison, WI). PCR
ampliﬁcation was performed with TaKaRa Ex Taq polymerase. The
puriﬁed PCR products were sequenced with primers for the direct
sequence and the ABI PRISM 3130 Genetic Analyzer (Applied
Biosystems, Foster, CA).
RT-PCR and allelic expression analyses among candidate genes
Using TRIzol (Invitrogen), we isolated total RNA from BDF1, DBF1
(DBA/2×C57BL/6), JBF1 (JF1×C57BL/6), and BJF1 (C57BL/6×JF1)
embryos at day 9.5. After total RNAwas treated with DNase (Promega)
to exclude the genomic DNA, the absence of genomic DNA
contamination was conﬁrmed by the lack of ampliﬁcation of GAPDH
by PCR. The genomic DNA-free total RNA was reverse transcribed to
cDNAwith SuperScript II (Invitrogen). The expression of 22 candidate
imprinted genes was examined by RT-PCR. The primer sequences and
PCR conditions are listed in Supplemental Table 1 and Supplemental
Table 2. To investigate the expression patterns of Zdbf2, different
tissues at various developmental stages (15.5-, and 18.5-day-old
embryos and 1- and 9-week-old mice) were harvested, and TRIzol
(Invitrogen, Carlsbad, CA) was used to extract total RNA.
5′-RACE analysis
The 5′-region of the mouse Zdbf2 gene was obtained using the
5′-Full RACE Core Set (TaKaRa). Total RNA was prepared from 9.5-
day-old BJF1 embryos, and a Zdbf2 gene-speciﬁc 5′-end phosphory-
lated primer (P2, 5′-ATTCCAAGGACTGCTGCTGT-3′) was used. We
performed 2 rounds of PCR by using TaKaRa LA Taq (TaKaRa) under
the following conditions: 25 cycles of 30 s at 94 °C, 30 s at 55 °C,
and 4 min at 72 °C for the ﬁrst PCR and 25 cycles of 30 s at 94 °C,
30 s at 60 °C, and 4 min at 72 °C for the second PCR. The primer sets
471H. Kobayashi et al. / Genomics 93 (2009) 461–472used for the nested PCR were as follows: Sense S1, 5′-TAGACCTGG-
TACTTCTCAGGAACA-3′ and anti-sense A1, 5′-CAACAGATCCTGAATCC-
TCGGAGT-3′ for theﬁrst PCR; sense S2, 5′-CACGCAGAAGTTGCAGTTCG-
3′ and anti-sense A2, 5′-TCTGCACCGCTATCTGCAG-3′ for the second
PCR. The ampliﬁed products were puriﬁed and directly sequenced.
DNA methylation analyses
Genomic DNA samples isolated from 9.5-day-old parthenogenetic,
androgenetic, and control embryos or from the sperm and oocytes of
adult BJF1 mice were treated with sodium bisulﬁte [26] using the
EpiTect Bisulﬁte Kit (QIAGEN, Valencia, CA). The bisulﬁte-treated DNA
was ampliﬁed by PCR with TaKaRa Ex Taq Hot Start Version (TaKaRa)
for CpG-rich regions around the mouse Zdbf2 gene. The primers and
PCR conditions for the ampliﬁcation are listed in Supplemental
Table 3. The PCR products were subcloned into pGEM-T Easy vector
(Promega), which was transformed into DH5α cells. Colonies were
selected and transferred into 96-well plates, and DNA was ampliﬁed
by rolling circle ampliﬁcation [54] with an Illustra TempliPhi DNA
ampliﬁcation kit (GE Healthcare Bio-Sciences, Little Chalfont, UK).
DNA was sequenced using standard primers (SP6, 5′-GATTTAGGTGA-
CACTATAG-3′ and T7, 5′-TAATACGACTCACTATAGGG-3′) and the ABI
PRISM 3130 Genetic Analyzer (Applied Biosystems). The percentage of
methylation was calculated as the number of methylated CpG
dinucleotides from the total number of CpGs at every CpG island
(CpG-rich region). At least 5 clones from each region and each
parental allele were sequenced.
Expression analysis of human ZDBF2
This study was approved by the Institutional Review Board
Committee at National Center for Child Health and Development,
and performed after obtaining written informed consent from each
subject or his or her parent(s). Genomic DNA was isolated from
human lymphocytes with the use of a FlexiGene DNA Kit (Qiagen).
Total RNA was extracted from human lymphocyte cell lines with
RNeasy Plus Mini Kit (Qiagen), and the total RNA from human
placentawas extractedwith ISOGEN (Nippon Gene, Tokyo, Japan). The
extracted RNAwas DNase-treated with deoxyribonuclease (RT Grade)
for heat stop (Nippon Gene). DNase-treated RNA was puriﬁed by
phenol/chloroform extraction. The genomic DNA-free total RNA was
reverse transcribed to cDNA with SuperScript III (Invitrogen). PCR
carried out in a 50-μl volume reaction mixture containing cDNA
(equivalent of 20–50 ng total RNA), 1× PCR buffer, 2.5 U of AmpliTaq
Gold (Applied Biosystems), 50 pmol of each primer, and 10 mM
dNTPs. The primers used for human ZDBF2 were 5′-AAACTGGA-
GAAGGGACAGCA-3′ and 5′-CAAATGAGCTGCTGGTGGTA-3′. The
cycling protocol was as follows: 1 min at 94 °C; 30 cycles of 94 °C
for 1 min, 57 °C for 1 min, and 72 °C for 1 min; and 5 min at 72 °C.
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